BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema

Melissa Pergakis(University of Maryland, Baltimore), J. Marc Simard(University of Maryland, Baltimore), Kevin N. Sheth(Yale University), Seemant Chaturvedi(University of Maryland, Baltimore), Neeraj Badjatia(University of Maryland, Baltimore), Carolyn Cronin(University of Maryland, Baltimore), W. Taylor Kimberly(Harvard University)

Expert Opinion on Investigational Drugs

October 18, 2019

10.1080/13543784.2019.1681967

Cited by 57

Related Papers

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

|Stroke|2019|7.2k

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

|Stroke|2018|5.5k

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

|Stroke|2022|1.5k

Defining Vasospasm After Subarachnoid Hemorrhage

|Stroke|2009|592

Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling

|Stroke|2014|526